Collegium Pharmaceutical (COLL) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $1.0.
- Collegium Pharmaceutical's EPS (Basic) rose 24482.76% to $1.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.85, marking a year-over-year decrease of 3248.18%. This contributed to the annual value of $2.14 for FY2024, which is 4965.03% up from last year.
- Per Collegium Pharmaceutical's latest filing, its EPS (Basic) stood at $1.0 for Q3 2025, which was up 24482.76% from $0.38 recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's EPS (Basic) ranged from a high of $2.06 in Q2 2021 and a low of -$0.73 during Q4 2021
- For the 5-year period, Collegium Pharmaceutical's EPS (Basic) averaged around $0.33, with its median value being $0.38 (2023).
- In the last 5 years, Collegium Pharmaceutical's EPS (Basic) plummeted by 46500.0% in 2021 and then skyrocketed by 600000.0% in 2023.
- Over the past 5 years, Collegium Pharmaceutical's EPS (Basic) (Quarter) stood at -$0.73 in 2021, then skyrocketed by 71.23% to -$0.21 in 2022, then surged by 571.43% to $0.99 in 2023, then plummeted by 60.61% to $0.39 in 2024, then surged by 156.41% to $1.0 in 2025.
- Its EPS (Basic) stands at $1.0 for Q3 2025, versus $0.38 for Q2 2025 and $0.08 for Q1 2025.